Evidence map›Paper›PMID 37497058›Full record

ReviewFrontiers in nutrition2023

A narrative review on the use of probiotics in several diseases. Evidence and perspectives.

Daniela Campaniello, Antonio Bevilacqua, Barbara Speranza, Angela Racioppo, Milena Sinigaglia, Maria Rosaria Corbo

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Investigation of probiotic, anticancer and antimicrobial activity of Enterococcus bacteria isolated from the gut microbiota of marine snails.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Viability-PCR for the selective detection ofFrontiers in microbiology · 2024
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daniela CampanielloDepartment of Agriculture, Food, Natural Resources and Engineering, University of Foggia, Foggia, Italy.
Antonio BevilacquaDepartment of Agriculture, Food, Natural Resources and Engineering, University of Foggia, Foggia, Italy.
Barbara SperanzaDepartment of Agriculture, Food, Natural Resources and Engineering, University of Foggia, Foggia, Italy.
Angela RacioppoDepartment of Agriculture, Food, Natural Resources and Engineering, University of Foggia, Foggia, Italy.
Milena SinigagliaDepartment of Agriculture, Food, Natural Resources and Engineering, University of Foggia, Foggia, Italy.
Maria Rosaria CorboDepartment of Agriculture, Food, Natural Resources and Engineering, University of Foggia, Foggia, Italy.
University of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbiota is a complex ecosystem, strictly linked to health and disease, as a balanced composition (referred as eubiosis) is necessary for several physiological functions, while an unbalanced composition (dysbiosis) is often associated to pathological conditions and/or diseases. An altered microbiota could be positively affected and partially restored through probiotic supplementation, among others. This review addresses the effects of probiotics in several conditions, used as case-studies (colorectal cancer, neuro-psychiatric diseases, intestinal diseases, obesity, diabetes, metabolic syndrome, immune system, and musculoskeletal system disorders) by pointing out the clinical outcomes, the mode of action, mainly related to the production of short chain fatty acids (SCFA), the impact of probiotic dose and mode of supplementation, as well as trying to highlight a hit of the most used genera.

Indexed as

clinical trialsdiseaseeffectsgeneraprobiotics

Identifiers

PMID37497058
PMCPMC10368401
OpenAlexW4383736518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.